This information was published on 2022-02-09T15:39:10 for IP Right Acceptance Published.
| Field | Value |
| (210) | 2246465 (IR 1642348) |
| (220) |
10 Dec 2021
|
| (300) |
US, 11 Jun 2021, 90769164
|
| (511) (510) |
Class 5
Pharmaceuticals for human use, namely, pharmaceutical preparations for treatment of cancer; pharmaceuticals for human use, namely, pharmaceutical preparations for treatment of oncological diseases, disorders, and conditions. |
| (540) | DECNUPAZ |
| (550) | Word |
| (730) |
ImmunoGen, Inc.
|
Find out more about publications on the About page.